NVS Today - Aug 10: FDA Approval Buzz

カートのアイテムが多すぎます

ご購入は五十タイトルがカートに入っている場合のみです。

カートに追加できませんでした。

しばらく経ってから再度お試しください。

ウィッシュリストに追加できませんでした。

しばらく経ってから再度お試しください。

ほしい物リストの削除に失敗しました。

しばらく経ってから再度お試しください。

ポッドキャストのフォローに失敗しました

ポッドキャストのフォロー解除に失敗しました

NVS Today - Aug 10: FDA Approval Buzz

無料で聴く

ポッドキャストの詳細を見る

Hey there! It’s Joey here, your friendly longtime investor breaking down the day for you. Today, we’re talking about Novartis, and it was a bit of a red day for them, down just a smidge – like 0.21%.

So, what went down? Well, Novartis barely moved today. It’s kinda like watching paint dry, you know? But there’s some buzz in the air about their drug Pluvicto getting FDA approval. That’s a big deal! It’s like a spotlight shining on them again.

Now, why did the stock react the way it did? Honestly, it looks like investors are still trying to wrap their heads around what this approval means for the company’s future. Some folks think it could really boost their sales, while others are just sitting back and waiting to see how this plays out. Plus, there’s chatter about Dr. Reddy’s stopping the marketing of Novartis brands starting in October, so that’s probably not helping the mood either.

Oh, and just so you know, JP Morgan is still keeping a Buy rating on the stock. So, there’s that! It’s always good to have some cheerleaders in your corner, right?

To wrap it up, Novartis had a quiet day with a little FDA excitement mixed in. Just keep an eye on how things evolve with Pluvicto and all the other noise around them. Remember, I'm just here to share the info and keep it fun. No financial advice from me! Catch you later!

まだレビューはありません